Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
23 déc. 2024 16h05 HE
|
Ceribell
SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...
Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing
19 nov. 2024 08h00 HE
|
Ceribell
—Ms. Rodenbush to lead hiring and talent development initiatives— —Mr. Price to focus on market development and penetration— SUNNYVALE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) --...
Ceribell Reports Third Quarter 2024 Financial Results
12 nov. 2024 16h05 HE
|
Ceribell
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs
11 nov. 2024 08h00 HE
|
Ceribell
—Ceribell System stands to reduce costly ICU admissions and intra-facility patient transfers— —Military veterans face elevated risks of developing seizure disorders— SUNNYVALE, Calif., Nov. ...
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
07 nov. 2024 16h05 HE
|
Ceribell
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...